Celularity Inc.

US$0.76As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CELUHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (49.13%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.88
PE TTM —
TSR TTM (61.02%)
Mkt cap US$24.67M
ROIC (140.98%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.894
17.66%
44.70%
Hold 6|4|6|0|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
12.24%
11.75%
3.50%
2.09%
Revenue$M
3.214
3.362
3.330
3.236
6.66%
7.84%
1.88%
0.96%
Peers (US$24.67M)
Cap (US$)
PE
24.40M
—
Capital
TTM
5Y
10Y
Leveragex
5.031
(0.165)
(0.164)
EBIT/Intx
0.115
0.194
0.211
Own earn%
(999.18)
50.42
44.26
Sh yield%
36.85
25.89
27.20
Owners
Insiders/Inst%
4.86
77.31
Short interest%
5.60
SBC / revenue%
2.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
27–34
$1 testx
0.0
Incr. ROIC%
9